؉ T-cell depletion and progression to simian AIDS (SAIDS). Virus recovered from a vaccinated macaque (Rh1490) that progressed to SAIDS had acquired an additional deletion in the nef gene, resulting in a frameshift that restored 
The nef gene is essential for achieving the full pathogenic potential of primate lentiviruses. In a seminal study, Kestler et al. showed that deletion of the nef gene markedly reduced the capacity of simian immunodeficiency virus (SIV) to induce AIDS in rhesus macaques (19) . Animals infected with SIV carrying a 182-bp deletion in nef were chronically infected but retained a low viral load for several years without signs of CD4 ϩ -T-cell depletion or progression to disease. Very similar characteristics have been reported in rare cases of human infections with human immunodeficiency virus type 1 (HIV-1) strains having nef deletions. Large nef deletions were initially documented in one hemophiliac patient infected since 1983 (21) and in an Australian cohort of six long-term nonprogressors (LTNP) who had been infected by blood from a single donor (10) . More subtle mutations, such as small deletions and point mutations that inactivate only some functions of Nef, have also been reported in LTNP (5, 20) . The notion that nef mutations can lead to virus attenuation is supported by the finding that forms with nef deletions can be detected in up to 10% of infections with HIV-2, a lentivirus associated with a longer clinical latency than HIV-1 (38) .
Lentiviruses with nef deletions were proposed as candidates for the development of live attenuated vaccines against HIV. In the rhesus macaque model, SIVmac with a nef deletion (SIVmac239⌬nef) did confer protection against superinfection with wild-type SIVmac239 and other closely related strains of SIV (9, 42) . Protection was dependent on the duration of SIVmac⌬nef infection and typically developed at around 10 to 15 weeks postvaccination (7, 18) . SIVmac carrying deletions in multiple accessory genes, including nef, also conferred protection, although vaccine efficacy correlated inversely with the degree of viral attenuation (18) . Live, attenuated SIV and HIV represent the most effective vaccine candidates developed to date, but the potential use of these viruses in humans has raised serious concerns about their safety. Forms of SIVmac with multiple deletions, such as SIVmac239⌬3, cause simian AIDS (SAIDS) in newborn macaques and occasionally in adult animals (2) . SIVmac239 carrying a 152-bp deletion in nef is frequently pathogenic in juvenile and newborn animals (34) . SIVmac239⌬nef, which has a 182-bp deletion in nef, can also induce SAIDS in adult animals. We have previously observed a rapid progression to disease in 1 out of 16 adult rhesus macaques that were vaccinated with SIVmac239⌬nef (7) . In addition, long-term follow up revealed a consistent decrease in CD4 ϩ T cells in other vaccinated macaques (R.I. Connor, unpublished observations). Recent findings with humans confirm that deletions in nef do not entirely eliminate HIV or SIV pathogenicity. Signs of disease progression, including loss of CD4 ϩ T cells, increase in viral load, and, in one case, occurrence of opportunistic infection, have been observed in the Australian cohort of HIV-⌬nef-infected patients after 14 to 18 years of follow-up (23) . Also, the hemophiliac patient who has been infected since 1983 now has depleted CD4 ϩ T cells, even though the viral load remains undetectable (14) .
An unresolved issue is the mechanism by which viruses with nef deletions can become pathogenic. Long-term low-level replication may be enough to progressively impair the host immune system. Alternatively, viral evolution in the host may lead to the emergence of variants with increased pathogenicity. One striking instance of evolution in SIV carrying nef deletions is the progressive accumulation of additional deletions within the region of nef that overlaps with the upstream U3 sequences in the long terminal repeat (LTR) (22) . Additional nef deletions also occur in humans, illustrating the parallel between HIV and SIVmac infections and the relevance of the simian model for nef analyses (10, 21) . Mutagenesis studies of SIVmac239 suggest that the role of the nef-U3 overlapping sequences is primarily to code for the C-terminal region of Nef rather than to contribute to LTR function (15) . Therefore, the accumulation of secondary nef deletions can be viewed as the result of selection pressures to remove nonfunctional sequences. However, additional deletions in nef can also result in gain-of-function mutations, when frameshifting puts the Cterminal part of the gene back in phase with the N-terminal part. Sawai et al. have shown that the synthesis of such truncated forms of Nef can be repeatedly selected for and can persist over time, raising the possibility that they contribute to virulence (34) .
The present study focuses on a case of rapid reversion of SIVmac239⌬nef to virulence. We demonstrate that the revertant virus has become pathogenic and has acquired the capacity to encode a Nef protein of intermediate length. Analysis of Nef properties shows that in spite of the absence of conserved core sequences, the truncated protein has retained the key capacity to increase viral replication in primary T cells.
MATERIALS AND METHODS

Animals and viruses.
Four adult rhesus macaques (Macaca mulatta) were used in this study. The animals were seronegative for SIV and type D retroviruses before the initiation of the experiments. All protocols used in this study were reviewed and approved by an institutional animal care and use committee. The 1490 virus stock was obtained by cocultivation of peripheral blood mononuclear cells (PBMC) obtained from animal Rh1490 on day 167 postinfection with phytohemagglutinin (PHA)-stimulated PBMC from an uninfected rhesus macaque. The titer of the viral stock was determined on CEMx174 cells as previously described (7) . The four naive rhesus macaques were infected by intravenous inoculation of 10 4 50% tissue culture infective doses of the 1490 viral stock on day 0. Blood samples collected in EDTA anticoagulant were used to determine SIV RNA levels in plasma, using a branched DNA (bDNA) signal amplification assay (Bayer Corporation) (8) . The lower quantification limit of this assay was 1,500 viral RNA copies/ml or plasma until April 1999, when the assay was modified by the manufacturer to a limit of sensitivity of 400 copies/ml. Additional viral load measurements were done by real-time PCR and reached a sensitivity limit of 50 copies/ml (28) .
Nef sequences. DNA was extracted from frozen PBMC obtained on either day 154 (macaque L259) or day 343 (macaques J344, J482, and L257) postinoculation by using a genomic DNA extraction kit (Qiagen). For comparison, DNA was also extracted from the original PBMC culture that was used to amplify the SIVmac1490 viral stock. A fragment encompassing the SIVmac nef gene was amplified by nested PCR with a mixture of Taq polymerase and the proofreading Pwo polymerase (Expand High Fidelity PCR system; Boehringer-Mannheim/Roche). PCRs were performed with the following primers: outer pair, TM1-Eco (5Ј-GGG AAT TCA AGA ATT GTT GCG ACT GAC CG-3Ј) and U5R1 (5Ј-AAA GCA GAA AGG GTC CTA ACA GAC CAG GG-3Ј); inner pair, preNhe (5Ј-CTG TTA AGA ATA GTG ATC TAT ATA GT-3Ј) and U5R2 (5Ј-GAC CAG GCG GCG ACT AGG AGA GAT GGG A-3Ј).
PCR products were cloned in the pGEM-T Easy vector (Promega) and sequenced in both orientations. Sequence reactions performed with fluorescent deoxy-and dideoxynucleotides were analyzed with an automated 373A sequencer (PE Applied Biosystems).
Plasmids. All SIVmac proviral constructs were based on pBR239E, which contains the full SIVmac239 genome (GenBank accession number M33262) inserted in a pBR322-based vector. This plasmid, which has an nef open reading frame and contains a unique EcoRI site added at the end of the 3Ј LTR, was a generous gift from Toshiaki Kodama (Oregon Regional Primate Research Center). The proviral clone that contains the two nef deletions, pSIVmac239-⌬2nef, was constructed by inserting the SacI-to-BspMI fragment (nucleotide [nt] 9486 to 10283 in sequence M33262) from clone 1490-27-7-1 into pBR239E. Proviral clone pSIVmac239-N contains three silent mutations in the N terminus of Nef, which cause amino acid changes in the Env. This plasmid was engineered by inserting the NheI-to-SacI fragment (nt 8998 to 9486) of clone 1490-27-7-1 into the pBR239E backbone. Proviral clone pSIVmac239-N⌬2nef, which contains both the Env transmembrane glycoprotein changes and the two nef deletions, was obtained by insertion of the 1490-27-7-1 NheI-to-BspMI fragment (nt 8998 to 10283) into pBR239E. The proviral clone that contains the original nef deletion, pSIVmac239⌬nef, was derived from plasmid p239SpE3Ј-⌬Nef, which was initially described by Kestler et al. and contains the 3Ј half of the SIVmac239 genome with a 182-bp nef deletion (19) . High-fidelity PCR was used to amplify p239SpE3Ј-⌬Nef sequences from the NheI site (nt 8998) to the 3Ј end of the genome and to add an EcoRI site at the 3Ј end. The NheI-to-EcoRI fragment was fully sequenced and inserted in pBR239E to generate pSIVmac239⌬nef. All pBR322-based plasmids containing SIVmac proviral genomes were propagated in JM109 bacteria grown at 30°C to limit the potential for recombination between the two LTR copies.
Introduction of a stop codon after the amino acid at position 20 of nef was done by PCR with overlapping mutagenic oligonucleotides. A 5Ј nef fragment (nt 9156 to 9405) was amplified with primers FcccXba (5Ј-TCG ATC TAG AAT ATA TTC ATT TCC TGA TCC GCC-3Ј) and Nefstop2R (5Ј-CCA CGC GCC CGC TAG AGT CTC TGT CG-3Ј). The 3Ј nef fragment (nt 9381 to 9736) was obtained with primers Nefstop2 (5Ј-CGA CAG AGA CTC TAG CGG GCG CGT GG-3Ј) and CpriR (5Ј-CTG TAA TAA ATC CCT TCC AGT CCC-3Ј) (mutated nucleotides are underlined). The two fragments were gel purified, joined by reamplification with FcccXba and CpriR, cloned in pGEM-Teasy vector (Promega), and sequenced. The resulting fragment was reinserted into clone pBR239E (containing the 239 wild-type genome) to yield p239-WTstop and into clone p239-⌬2nef (containing the ⌬2 deletion) to yield p239-⌬2nef stop.
Inserts for bicistronic Nef expression vectors were generated by amplification of nef sequences with primers FcccXba and RLTRcBam (3Ј-TCG AGG ATC CCA GGG CTC AAT CTG CCA GCC TC-3Ј) by high-fidelity PCR. Inserts were sequenced, digested with XbaI and BamHI, and cloned into the NheI and BamHI sites of the pIRES2-EGFP vector (Clontech). The resulting constructs contained the nef and enhanced green fluorescent protein (EGFP) genes separated by an internal ribosome entry site, which permitted both genes to be translated from a single bicistronic mRNA.
To generate Nef-GFP fusion proteins, nef sequences were inserted into the pEGFP-N3 vector (Clontech) so that the nef open reading frame was in phase with that of EGFP. Nef sequences (plus 177 bp of 5Ј flanking sequences) were amplified with primers FcccXba and R-3Јnef-Bam (5Ј-GAT GGA TCC GCG AGT TTC CTT CTT GTC AGC-3Ј), sequenced, digested with XbaI and BamHI, and inserted into the polylinker of pEGFP-N3.
To generate LTR-luciferase reporter plasmids, a SacI-to-HincII fragment (nt 9486 to 10450) encompassing a 3Ј fragment of the env gene, the whole of U3 and R, and 35 bp of U5 was cloned into the polylinker of pGL3-Basic (Promega). The resulting constructs expressed the luciferase gene under the control of the SIV LTR.
Infections. Viral stocks were generated by transfection of 3 g of genomic SIVmac plasmids in 293T cells plated at 4 ϫ 10 5 cells/well in six-well plates. Transfection was performed with the DMRIE-C reagent according to the recommendations of the manufacturer (Gibco-BRL). Cell culture supernatants were harvested at 72 h posttransfection, centrifuged at 800 ϫ g, filtered through 0.45-m-pore-size filters, and stored at Ϫ70°C until use. The amount of SIV was quantified by using a p27 Gag enzyme-linked immunosorbent assay kit (Beckman Coulter). Normalized viral stocks containing 50 ng of p27 Gag antigen were used to infect 10 7 unstimulated human or macaque PBMC for 3 h at 37°C. The cells were then washed and cultivated at 3 ϫ 10 6 cells/ml in RPMI 1640 medium supplemented with 10% fetal calf serum, penicillin, and streptomycin (RPMI-c). Cultures were stimulated 2 days postinfection by addition of PHA at 1 g/10 6 cells and interleukin-2 (IL-2) at 10 U/ml. Viral production was monitored by measurement of SIV p27 Gag in culture supernatants.
Single-cycle infectivity assays (or Magi assays) were done with HeLa-derived cell lines that expressed CD4 and a relevant coreceptor and that were transduced with the ␤-galactosidase gene under the control of the HIV-1 LTR. P4-R5 cells expressing human CCR5 (provided by Pierre Charneau, Institut Pasteur) were propagated in Dulbecco's modified Eagle medium plus 10% fetal calf serum, penicillin, and streptomycin (DMEM-c) supplemented with 1 g of puromycin per ml. Magi-RhR5 cells expressing rhesus macaque CCR5 (provided by Zhiwei Chen, Aaron Diamond AIDS Research Center [ADARC]) were propagated in DMEM-c with 200 g of G418 per ml and 1 g of puromycin per ml. The cells were plated at a density of 4 ϫ 10 4 cells/well in 24-well plates and infected the next day with viral supernatants containing 20 or 50 ng of SIV p27 Gag antigen in the presence of 10 g of DEAE-dextran per ml. On day 3 postinfection, the cells were fixed in 1% paraformaldehyde and 0.2% glutaraldehyde, washed, and incubated in staining solution containing 1ϫ phosphate-buffered saline (PBS), 4 mM potassium ferrocyanide, 4 mM potassium ferricyanide, 2 mM MgCl 2 , and 400 g of X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) per ml. Cell were stained for 50 min to 2 h at 37°C in a non-CO 2 incubator and washed twice in PBS. The number of blue cells per well was counted under an optical microscope.
Immunoblot. CEMx174 cells were resuspended in 100 l of protein extraction buffer containing 50 mM Tris (pH 8.0), 137 mM NaCl, 2 mM EDTA, 10% glycerol, 1% Nonidet P-40 detergent, and the protease inhibitors aprotinin, leupeptin, and Petablock at 1 g/ml each. The protein extracts were incubated for 10 min on ice and clarified in an Eppendorf microcentrifuge for 10 min at 14,000 rpm. Extracts were resuspended in 2ϫ sodium dodecyl sulfate loading buffer for analysis by immunoblotting as previously described (26) . To detect deletion forms of the Nef proteins, samples were run on a 12% polyacrylamide gel and immunoblotted with a polyclonal rabbit anti-SIVmac Nef serum generously provided by Paul Luciw (University of California, Davis) (34) . Nef-GFP fusion protein expression in transfected HEK 293T cells was detected with an anti-GFP antibody (Santa Cruz Biotechnology) used at a 1:10,000 dilution.
Fluorescence imaging. 293T cells were seeded onto round coverslips coated with poly-L-lysine and were grown in DMEM-c. The cell were transfected the next day with Nef-GFP fusion vectors by using the DMRIE-C reagent (Gibco-BRL). Transfected cells were fixed after 48 h in PBS with 1% paraformaldehyde. Cells attached to the coverslips were mounted in Vectashield medium with DAPI (4Ј,6Ј-diamidino-2-phenylindole) (Vector laboratories). Images were obtained and deconvolved through a DeltaVision restoration microscopy system utilizing Softworx software (Applied Precision).
Analysis of LTR transcriptional activity. LTR-luciferase plasmid constructs were electroporated into Jurkat-E6 cells (provided by Rong Liu, ADARC). Twenty micrograms of plasmid DNA resuspended in 50 l of 0.15 M NaCl was used per electroporation. Each DNA sample consisted of 10 g of the pLTR-luc construct to be tested, 5 g of the HIV-1 Tat expression vector pTat13, and 5 g of the constitutive ␤-galactosidase expression vector pBC12/CMV/lacZ (27) . Cells were grown in RPMI-c and maintained at concentrations lower than 3 ϫ 10 5 cells/ml prior to each experiment. 10 7 cells were resuspended in 200 l of RPMI-c and added to 50 l of DNA mix in 0.4-cm electroporation cuvettes. Electroporation was carried out at 250 V and 960 F by using a Gene Pulser II apparatus with capacitance extender (Bio-Rad). Luciferase and ␤-galactosidase activities were tested 24 to 48 h later with the Luciferase Assay System (Promega) and the Galacto-Star (Tropix) kits.
Flow cytometry. The downregulation of cell surface markers was evaluated by flow cytometry in cells expressing Nef constructs. Three types of Nef-expressing cells were generated. HeLa-CD4 cells were transfected with bicistronic Nef/ EGFP expression vectors. Jurkat E6 cells, which express CD3, were electroporated with bicistronic Nef/EGFP plasmids as described above. To evaluate major histocompatibility complex class I (MHC-I) downregulation, the reporter cell line CEMx174 5.25 (a kind gift from Nathaniel Landau, Salk Institute) was infected with SIVmac clones. This cell line is stably transduced with CCR5 and with an HIV-1-LTR-GFP reporter construct, so that infected cells are positive for GFP expression. Antibodies used for surface staining included anti-CD4-allophycocyanin (Exalpha, Boston, Mass.), anti-CD3-phycoerythrin (clone SP34; PharMingen BDIS), and anti-HLA class I-phycoerythrin (clone MHBC04; Caltag). Cells were resuspended in 100 l of PBA buffer (PBS plus 1% bovine serum albumin and 10 mM NaN3), incubated for 15 min at room temperature in the presence of labeled antibodies, washed in PBA buffer, and resuspended in PBA buffer with 1% paraformaldehyde. Analyses were performed by using a FACSCalibur flow cytometer with Cellquest software (Becton Dickinson). All analyses were performed on the GFP-positive population, which corresponded to Nef-expressing cells. Negative controls for GFP labeling consisted of cells transformed with the empty plasmid vector pCG or uninfected cells. The negative control for Nef expression consisted of cells transfected with the vector pIRES2-EGFP. The specificity of surface marker staining was assessed with isotypematched control antibodies.
Nucleotide sequence accession numbers. The nucleotide sequences of the nef gene for the seven clones represented in Fig. 2 have been deposited in GenBank and are available under accession numbers AY129655 to AY129661.
RESULTS
The 1490 isolate is pathogenic. Previously, we reported on a case of disease progression in a rhesus macaque inoculated with live, attenuated SIVmac239⌬nef (7). Infection in macaque Rh1490 was characterized by a peak viremia of 5 ϫ 10 6 viral RNA copies/ml, a high viral load during the chronic stage of infection (up to 10 6 copies/ml), and a subsequent loss of CD4 ϩ T cells. This animal was challenged with SIVmac251 at 10 weeks after SIVmac239⌬nef inoculation, but the challenge virus remained undetectable by repeated nested-PCR testing of blood and lymph node samples, suggesting that pathogenic progression was due to replication of SIVmac239⌬nef. At 2 years postinoculation, macaque Rh1490 had severely depleted CD4 ϩ T cells (100 cells/mm 3 ), developed SAIDS, and was euthanized. Viral sequences amplified from plasma and PBMC revealed an evolution of the nef gene, with the acquisition of additional nef deletions that became predominant at 12 weeks after infection and persisted at later time points (7) .
The isolate obtained from animal Rh1490 at day 167 was propagated in macaque PBMC to generate a viral stock (SIVmac1490). The virus was then passaged into four naive adult rhesus macaques by intravenous inoculation of 10 4 50% tissue culture infective doses of SIVmac1490. Peak viremia in the four macaques ranged between 10 6 and 10 7 viral RNA copies/ml (Fig. 1A) . Comparison with historical controls showed that macaques infected with SIVmac1490 had significantly higher viremia peaks than macaques infected with the original SIVmac239⌬nef clone, with mean viral RNA copy numbers of 4 ϫ 10 6 versus 1 ϫ 10 6 /ml (Fig. 1C) (7) . However, SIVmac1490 still induced lower viremia peaks than the highly pathogenic SIVmac251 isolate (mean RNA copy number for SIVmac251, 7 ϫ 10 7 /ml). Three of the four macaques inoculated with the 1490 isolate showed signs of CD4 depletion and disease progression (Fig. 1B) . Animal L259 progressed rapidly to disease and was euthanized on day 193 because of wasting associated with chronic diarrhea. This animal had a transient rebound of viremia that preceded a drop of CD4 ϩ -T-cell numbers, and it died with depleted CD4 ϩ T cells (145/mm 3 ) and signs of colitis. Animal J482 maintained a chronically high viral load and developed SAIDS at 1.5 years after inoculation. At necropsy, VOL. 77, 2003 TRUNCATED SIV Nef INCREASES VIRAL REPLICATION 1247 J482 had a low CD4 ϩ T-cell count (230/mm 3 ), a viral load of 2 ϫ 10 4 copies/ml, and evidence of opportunistic infection with Pneumocystis carinii. Macaque L257 developed signs of disease and was euthanized 2 years postinoculation, with moderate
CD4
ϩ T-cell depletion (464/mm 3 ) and undetectable viremia as measured by bDNA assays (Ͻ400 RNA copies/ml). Additional testing by real-time PCR, using primers and a molecular beacon that surround the original nef deletion (28), also yielded
FIG. 1. Viral load and CD4
ϩ -T-cell counts in macaques infected with SIVmac with nef deleted. (A and B) Number of viral RNA copies per milliliter of plasma (A) and number of CD4 ϩ T cells per cubic millimeter of blood (B) for the SIVmac239⌬nef-infected animal (1490) that spontaneously progressed to disease and the four rhesus macaques (J344, J482, L257, and L259) inoculated with the SIVmac1490 isolate. ϫ, time of death. The viral load was measured by the bDNA assay (8) , which had a lower detection limit of 1,500 copies/ml until day 370 and of 400 copies/ml afterwards. p.i., postinfection. (C) Comparison of peak viral RNA values induced by different SIVs during primary infection. Data for animals infected with the pathogenic isolate SIVmac251 and the attenuated molecular clone SIVmac239⌬nef were obtained from a previous study (7) . Comparisons between groups were made with the nonparametric Mann-Whitney test (P values are indicated above arrows; median values are indicated by horizontal bars).
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undetectable viremia, with a threshold of detection of 50 copies/ml. Necropsy findings included colitis complicated by amyloid deposits in the small intestine and lymphoid hyperplasia. The fourth macaque, J344, had moderately depleted CD4 ϩ T cells (466/mm 3 at day 683) and remained healthy throughout a 2-year observation period. These findings showed that the SIVmac1490 isolate was more pathogenic than SIVmac239⌬nef, since three out of four inoculated macaques progressed to disease within 2 years of infection. Pathogenesis induced by SIVmac1490 virus nevertheless differed from that induced by wild-type SIVmac in that clinical progression could occur in the presence of a moderate to low plasma viral load.
The nef-⌬2 deletion is maintained upon in vivo passage. We characterized the nef deletions present in the 1490 virus isolate and its evolution upon in vivo passage. DNA was extracted from the macaque PBMC used to propagate the 1490 virus stock and from the PBMC of the four inoculated macaques. A 1.2-kb fragment encompassing the nef open reading frame was amplified by high-fidelity PCR, cloned, and sequenced ( Fig.  2A) . Genetic analysis revealed that the 1490 virus had acquired a 112-bp deletion in addition to the original 182-bp deletion present in the SIVmac239⌬nef clone. Interestingly, the second deletion, termed ⌬2, reversed the frameshift introduced by the original deletion and led to a longer nef open reading frame (Fig. 2B) . The predicted Nef-⌬2 protein was 165 amino acids (aa) in length and lacked the acidic domain and most of the conserved core region of wild-type Nef (Nef-WT). However, it retained the flexible N-terminal domain and the long C-terminal domain specific to SIVmac. Importantly, the ⌬2 deletion preserved the cis-acting sequences needed for viral replication, including the U box, the polypurine tract, the att site needed for integration, and the viral enhancers (16, 33) . Nef sequences from the four inoculated macaques were analyzed at either 6 months (L259) or 1 year (L257, J344, and J482) postinoculation. Sequence alignment showed that the ⌬2 deletion was conserved upon in vivo passage (Fig. 2A) . The predicted amino acid sequence of nef was unchanged in three macaques (L257, L259, and J344), while in the fourth (J482), nef acquired a third deletion of 132 bp which resulted in a predicted protein of 122 aa lacking most of the C-terminal domain. Clones from J482 also contained nonconservative amino acid substitutions that suggested a possible loss of Nef function. For each animal, the PCR products obtained from PBMC DNA were homogeneous in size, suggesting that the deletions identified in sequenced clones were representative of the viral quasispecies in vivo (data not shown). Evaluation of nucleotide substitutions in nef indicated that the maximum divergence was of 0.65% for macaque J344 (not taking the deletion into account) and 0 to 0.25% for the other three animals. Thus, in most macaques, sequences coding for Nef-⌬2 showed little genetic evolution upon in vivo passage.
The truncated form of Nef is expressed and localizes to a vesicular compartment. We next assessed whether the truncated form of Nef could contribute to SIV replication and thus account for the pathogenic phenotype of SIVmac1490. We chose to focus on the Nef-⌬2 form that predominated in Rh1490 and in three out of four reinoculated macaques. Constructs were derived from a clone that represented the consensus sequence of the 1490 isolate. An NheI-to-BspMI fragment encompassing the nef gene of SIVmac1490 clone 27-1-1 was introduced in the SIVmac239 genetic backbone. The resulting clone, SIVmac239-N⌬2nef, differed from SIVmac239 by the presence of the two deletions in addition to three point mutations in the N terminus of nef (C9063T, A9110G, and C9263T). These mutations were silent in nef but changed the amino acid sequence of the overlapping env open reading frame (T735I, R751G, and L802F). To rule out possible effects of env mutations, we also constructed clone SIVmac239-⌬2nef, which contained the two nef deletions but not the three point mutations. An additional control consisted of the reciprocal construct SIVmac239-N, which contained the three point mutations in env but not the nef deletions (Fig. 2B ).
Nef expression was tested by immunoblotting with protein extracts from infected CEMx174 cells and a polyclonal anti-SIV Nef rabbit serum for detection. Cells infected with the SIVmac1490 isolate were found to express a truncated form of Nef that migrated with an apparent molecular mass of approximately 23 kDa (Fig. 3A) . This was slightly higher than the (Fig. 3B) . The lower expression levels detected for Nef-⌬2 compared to Nef-WT could be attributed in part to the absence of epitopes recognized by the polyclonal rabbit serum. Indeed, when expressed as GFP fusions in transfected HEK 293T cells, comparable amounts of Nef-⌬2-GFP and Nef-WT-GFP proteins could be detected with an anti-GFP monoclonal antibody (Fig. 3C ). An even smaller form of Nef could be detected in cells infected with SIVmac239⌬nef but was absent from cells infected with SIVmac239-nef stop, which has a nonsense codon at position 93 in Nef (Fig. 3B) . The Nef-⌬ protein had an apparent molecular mass of 8 to 10 kDa, compatible with a predicted molecular mass of 8.5 kDa. Therefore, truncated Nef proteins consisting of the N-terminal domain only or the joint N-and C-terminal domains were expressed in the context of a productive SIVmac infection. HEK 293T cells transfected with Nef-GFP expression vectors were examined by fluorescence deconvolution microscopy to assess whether the presence of the ⌬2 deletion had any effect on Nef subcellular localization. Nef-⌬2-GFP localized mainly to a vesicular compartment, similar to the wild-type protein Nef-WT-GFP (Fig. 4) . Minor differences in the repartition of GFPpositive vesicles were observed, with Nef-WT-GFP localizing mainly to a perinuclear area, while Nef-⌬2-GFP was more homogeneously distributed in cytoplasmic vesicles. The vesicular localization of Nef-⌬2 suggests that this protein retained the capacity to interact with the endocytic machinery.
Nef⌬2 does not downregulate cell surface receptors. To assess the functional properties of Nef-⌬2, we engineered bicistronic expression vectors that coded for both Nef and EGFP proteins. Transfection of these vectors in HeLa-CD4 cells and analysis of the GFP-positive population by flow cytometry allowed the evaluation of CD4 expression in the subpopulation of cells that expressed Nef (Fig. 5A) . As expected, Nef-WT caused a downregulation of CD4 cell surface expression. In contrast, Nef-⌬2 gave a CD4 expression profile indistinguishable from that of Nef-⌬ (Fig. 5A) or a control GFP vector (not shown). Electroporation of Nef expression vectors in Jurkat-E6 cells showed that, in the context of a T lymphoid cell line, Nef-WT downregulated both the CD4 and CD3 receptors. Within the GFP-positive population, 80% of the CD3 low cells were also CD4 low , supporting the notion that Nef has a dual effect on CD4 and CD3. In contrast, expression of Nef-⌬2 did not modify the surface expression of either of these receptors (Fig. 5B) . We next assessed the effect of Nef on MHC-I expression levels. Downregulation of MHC-I in Jurkat cells by the Nef-WT expression vector was low but detectable (not shown). To better evaluate the effect of Nef on MHC-I expression, additional experiments were performed in the context of a productive SIV infection. (Fig. 5C ). This set of experiments shows that the truncated Nef-⌬2 protein has lost the capacity to downregulate the surface receptors CD4, CD3, and MHC-I. Nef-⌬2 increases SIVmac replication in unstimulated primary cells. A key property of HIV and SIV Nef proteins is the ability to increase viral replication in unstimulated primary T cells. To test whether this property was retained by Nef-⌬2, unstimulated human PBMC were infected with virus produced from the different SIVmac molecular clones after first normalizing for p27 Gag antigen concentration. Cultures were stimulated at 2 days postinfection with PHA and IL-2, and were monitored for p27 Gag production for 3 weeks. This culture protocol has been successfully used to reveal the delayed replication kinetics of Nef mutants in PBMC cultures (29, 36) . As shown in Fig. 6A , SIVmac239-⌬2nef and SIVmac-239-N⌬2nef showed replication levels that were intermediate between those of the wild-type virus and those of SIVmac239⌬nef. A similar phenotype was observed in rhesus macaque PBMC cultures, where viruses carrying the Nef-⌬2 deletion reached p27 levels close to those obtained with the wild-type virus 2 weeks after infection (Fig. 6B) . Since SIV replication in PBMC culture is known to be variable and to depend on the donor, we repeated the infection experiments five times, using different human PBMC donors and two independent viral stocks. In each case, SIVmac239-⌬2nef replicated to levels intermediate between those seen with wild-type SIVmac239 and SIVmac239⌬nef. For each experiment, p27 values were compared at the day of peak viral replication for the wild-type virus (Fig. 6C ). This analysis confirmed that SIVmac239-⌬2nef replicated to higher levels than SIVmac239⌬nef and to lower levels than wild-type SIVmac239, with the differences being statistically significant (P ϭ 0.03 in both cases). Therefore, the Nef-⌬2 allele partially restored SIV replication capacity in primary T cells. No significant differences were observed between the replication of SIVmac239-⌬2nef and SIVmac-239-N⌬2nef (Fig. 6A and B) , indicating that the three point mutations in env did not modify SIVmac replication in a primary T-cell culture system. Infectivity of the different SIV molecular clones was next assessed in single-cycle Magi assays. Viral supernatants normalized for p27 Gag content were used to infect HeLa-CD4 cells transduced with an LTR-␤-galactosidase reporter cassette and human CCR5 (P4-R5 cells) (Fig. 6D) . The infectivity of viruses carrying the ⌬2 deletion was indistinguishable from that of SIVmac239⌬nef or SIVmac239-nefstop and was reduced fivefold compared to that of clones expressing Nef-WT (Fig. 6D) . Similar experiments were conducted with Magi-RhR5, a second indicator cell line that expresses rhesus macaque CCR5. This cell line proved to be more susceptible to SIV infection and gave a higher differential (15-to 20-fold) between the infectivities of wild-type and mutant clones. Even with this more sensitive assay, the infectivities of SIVmac-239⌬2nef and SIVmac-239N⌬2nef did not differ significantly from that of SIVmac239-nefstop (Fig. 6E) . Taken together, these data showed that infectivity enhancement in fibroblastic cell lines and increased viral replication in primary T cells were properties that could be dissociated. The truncated Nef-⌬2 protein facilitated SIV replication only in primary T cells, suggesting that this phenotype was dependent on T-cellspecific factors.
Increased viral replication depends on Nef expression. The ⌬2 deletion modified the structure of the Nef protein but also that of the overlapping U3 region of the LTR. In particular, this deletion resulted in the loss of modulatory sequences located 5Ј to the enhancer. It was therefore possible that the increased replication of SIVmac239-⌬2nef in primary T cells was due to altered transcriptional activity of the LTR. To test this possibility, we engineered LTR-luciferase constructs in which a SacI-to-HincII fragment encompassing the U3 and R regions of the SIV LTR drove the expression of a luciferase reporter gene. Jurkat E6 cells were electroporated with LTRluciferase constructs, a Tat expression vector, and a ␤-galactosidase expression vector that was used to control for transfection efficiency. The transcriptional activity, as measured by the ratio of luciferase activity to ␤-galactosidase activity, did not differ markedly between the different LTR constructs (Fig. 7) . pLTR-⌬2 was approximately 25% more efficient than pLTR-WT at driving luciferase expression and had an activity comparable to that of pLTR-⌬. All of the reporter constructs had similar activities when transfected in HeLa cells (not shown).
Since the ⌬2 deletion did not appear to markedly increase LTR transcriptional activity, a direct effect of the truncated Nef protein on viral replication seemed more likely. To test whether Nef-⌬2 expression was indeed required for increased viral replication, we engineered an SIVmac molecular clone in which the Nef-⌬2 open reading frame was interrupted by a premature termination codon after the amino acid at position 20. Infection of unstimulated human PBMC with the resulting clone, SIVmac239-⌬2nefstop, resulted in replication levels that were clearly decreased compared to those of SIVmac239-⌬2nef and that were equivalent to those of SIVmac239⌬nef (Fig. 8) . As a control, we verified that introduction of a nonsense codon at the same position in wild-type SIVmac239 also resulted in limited viral replication. Taken together, these results demonstrate that expression of the truncated Nef-⌬2 protein facilitates SIV replication in primary T cells.
DISCUSSION
This study provides evidence that SIVmac encoding a truncated Nef protein lacking the central core region is pathogenic in rhesus macaques. The virus from Rh1490, which contains two large deletions in nef, was passaged into naive macaques and induced disease in three out of four animals within 2 years. This isolate proved to be more pathogenic than the original SIVmac239⌬nef virus, which caused disease in only 1 of 16 rhesus macaques within the same time frame (7) . We propose that evolution of viral nef sequences contributed to restore the pathogenicity of SIVmac1490, although we cannot rule out that changes in other regions of the genome also played a role in the observed phenotype. Major changes were detected in the SIVmac1490 nef gene, notably, the acquisition of an additional deletion, which restored the original nef open reading frame in the 3Ј region. We sought to determine whether these combined deletions in nef could contribute to the recovery of a functional protein. Analysis of Nef properties revealed that the truncated protein Nef-⌬2 retained the capacity to increase viral replication in primary T cells. Other Nef functions such as cell surface receptor downregulation and infectivity enhancement in HeLa cell were lost, suggesting that these properties are not strictly required for SIV pathogenicity. The increase in viral replication conferred by Nef-⌬2 remained lower than that conferred by Nef-WT, which was compatible with the intermediate pathogenicity of the isolate SIVmac1490 compared to that of wild-type SIVmac239 (Fig. 1C and 6C) . The parallel observed between in vitro and in vivo phenotypes suggests that Nefmediated enhancement of viral replication in primary T cells is a key determinant of SIV pathogenicity. The mechanism responsible for the effect of truncated Nef proteins on viral replication remains to be elucidated. Nef-⌬2 lacks the conserved central regions that form the structural core of the protein and that have been implicated in several Nef properties, including interaction with the SH3 domain of kinases, interaction with PAK kinase, and infectivity enhancement in HeLa cells (reviewed in references 11, 12, 31, and 35) . Some of the key residues involved in the interaction of SIV Nef with CD4, MHC-I, and the zeta chain of the CD3 receptor are also missing, which likely accounts for the loss of downregulation of these molecules. Nef-⌬2, however, retains most of the N-terminal and C-terminal flexible regions, which have multiple interaction partners. In particular, the N-terminal fragment contains the bipartite membrane targeting domain that is essential to every Nef function described thus far. The N-terminal region of Nef interacts with a complex formed by Lck and a serine kinase (NAKC) (3) and also binds directly to the p85 subunit of phosphatidylinositol 3-kinase, which can induce antiapoptotic signals (41) . Both of these interactions are important for the enhancement of viral replication in T cells and may contribute to the Nef-⌬2 phenotype.
Most residues important for Nef interaction with the cellular trafficking machinery are present in Nef-⌬2, including the Nterminal tyrosine-based motif (Y28xxL,Y39xxS) and the C- terminal leucine-based motif (L194M), both of which can mediate binding to clathrin adaptor complexes (4) . The acidic region that has been implicated in the binding of HIV-1 Nef to PACS, a protein that controls endosome-to-Golgi trafficking, is deleted in Nef-⌬2 (32), but a putative PACS1 interaction motif is still present in the C-terminal loop region of SIV Nef (12) . The conservation of these motifs may account for the vesicular localization of Nef-⌬2. It should be noted, however, that the distribution of Nef-⌬2 differed from that of Nef-WT by a more homogeneous repartition in cytoplasmic vesicles. It is possible that the loss of interaction with partners such as CD4 and MHC-I alters the routing of Nef-⌬2 to vesicular compartments.
The finding that Nef-⌬2 expression facilitates SIV replication in unstimulated primary T cells but does not increase single-cycle infectivity in HeLa cells indicates that these two properties can be dissociated and are not necessarily attributed to the same function of Nef. In the case of HIV-1 Nef, mutations that impair single-cycle infectivity but not replication in PBMC localize to the N-terminal region (Nef ⌬7-22) and to the proline motif in the central core region (25, 39) . The capacity of HIV-1 Nef to increase viral replication in PBMC has been correlated with its capacity to downregulate CD4 (13, 25) . Interestingly, this relationship was not observed for SIV Nef, since the Nef-⌬2 protein retained the capacity to increase viral replication but failed to downregulate CD4. These observations suggest that similar functions of HIV-1 and SIV Nef can be encoded by different structural determinants, a notion that is also supported by studies of CD4 and MHC-I downregulation (24, 37) , and Hck binding (30) .
The persistence of sequences coding for Nef-⌬2 in Rh1490 (7) and their conservation in three out of four inoculated rhesus macaques suggest that these sequences are under positive selection pressure and contribute to the emergence of a virulent phenotype. However, an additional Nef deletion occurred in animal J482, which still progressed to disease. The presence of nonconservative changes in the remaining Nefcoding sequences amplified from this animal (Fig. 2) probably reflects a loss of selection pressure for a functional Nef protein.
Therefore, reversion to virulence may also occur through mechanisms that do not primarily depend on Nef. It cannot be ruled out that accumulation of large deletions within the U3 region of the LTR improves HIV and SIV replication in vivo, even though effects on viral transcription appeared to be limited in vitro (this study and references 15 and 33). Improvement of LTR function may account for the progressive accumulation of U3 deletions observed in several LTNP infected with nef deletion HIV-1 (10, 21) . Large U3 deletions were often accompanied by duplication of NF-B and Sp1 binding sites, which may contribute to increasing the efficiency of viral transcription (10) . It should be noted that changes in other regions of the genome may also contribute to virulence. For instance, the sequence of SIVmac239 was shown to be less than optimal for viral replication, based on the consistent appearance of the same mutations in pol and rev/env genes when rhesus macaques were inoculated with virus generated from this molecular clone (1) .
There are clear indications that selection for expression of a truncated Nef protein can play a role in reversion to virulence. In the present study, both macaques Rh1490 and L259 experienced a decline in CD4 ϩ T cells while infected with a virus that expressed the truncated 23-kDa protein Nef-⌬2. In another study, rhesus macaques inoculated with SIVmac239 carrying both a mutated nef initiation codon and a 152-bp deletion in nef developed SAIDS in roughly 50% of cases (34) . Reversion to virulence was associated with reopening of the nef open reading frame and with the expression of a 25-to 27-kDa Nef protein that was maintained over time. In the case of more limited nef deletions, reversion to a virulent phenotype is often accompanied by a repair of missing nef sequences. For instance, spontaneous repair of the 12-bp nef deletion in clone SIVmacC8 was associated with disease progression in infected rhesus macaques (40) . Selection for Nef repair was also evidenced in HIV-1 from one LTNP, for which 36 bp missing in nef was partially restored by duplication of adjacent sequences (5) . The duplication resulted in the recovery of some Nef functions, including the ability to downregulate MHC-I and to enhance virus infectivity. In the case of point mutations in nef, reversion is extremely rapid as demonstrated by the reopening of the nef open reading frame in SIVmac239-nefstop-infected animals by the second week postinoculation (6, 19) . Therefore, selection pressures appear to have different outcomes depending on the nature of the inactivating mutations in nef: small deletions and point mutations can be repaired, while larger deletions allow only partial restoration of Nef functions. In the case of the largest deletions, the selective advantage of expressing a truncated Nef protein may be equivalent to or lower than that associated with the loss of U3 sequences, which would account for the accumulation of additional deletions. The pathogenesis induced by SIV with Nef deletions appeared to differ from that induced by wild-type SIVmac. It was intriguing in particular that animal L257 progressed to disease while maintaining an undetectable viral load. The use of a sensitive real-time PCR assay showed that the concentration of viral RNA in plasma remained below 50 copies/ml even at the time of necropsy. Another animal, L259, had a low viral load at the time of death. We have also observed that, in the long term, certain rhesus macaques inoculated with SIVmac239⌬nef start showing signs of CD4 ϩ T-cell decrease, even in the absence of a detectable viral load (unpublished observation). A parallel can be made with findings for some LTNP infected with HIV-1 with nef deleted. In the case of a hemophiliac patient infected since 1983, CD4 ϩ T-cell counts decreased to 261/mm 3 in 1998, even though the plasma viremia remained undetectable throughout the period of observation (14) . In the Sydney Blood Bank cohort, three patients who showed signs of progression had a detectable viral load, although the number of viral RNA copies in plasma remained moderate (median of fewer than 2,850 copies/ml) with respect to the slope of CD4 ϩ -T-cell depletion (23) . These observations suggest that pathogenic progression induced by HIV and SIV with nef deleted differs from that induced by the wild-type virus, either in the extent of viral replication or in the efficiency of trapping of viral particles in lymphoid organs. Further analysis of specific pathogenic traits associated with lentiviruses with nef deleted should provide new insights into the links between viral replication, CD4 ϩ T-cell depletion, and immune system dysfunction.
